Jane Street’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Other funds holding XERS
Jane Street's XERS Position: Q3 2026 in Review
Jane Street increased its Xeris Biopharma Holdings (XERS) stake by 276% in Q3 2026, buying an estimated $1.45M and bringing the position to 233,034 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #4960.
Jane Street first reported a position in XERS in Q4 2020 and has held it in 24 quarters since. The position peaked at $7.44M in Q3 2025. 249 funds tracked by Wall St. Rank hold XERS as of Q3 2026.
- Jane Street held 233,034 shares of Xeris Biopharma Holdings worth $2.23M as of Q3 2026.
- Jane Street bought 171,119 Xeris Biopharma Holdings shares in Q3 2026, an estimated $1.45M.
- Xeris Biopharma Holdings made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #4960 holding.
- Jane Street first reported a position in Xeris Biopharma Holdings in Q4 2020 and has held it in 24 quarters since.
- Jane Street's Xeris Biopharma Holdings position peaked at $7.44M in Q3 2025.
- 249 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.